Literature DB >> 17496894

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Maureen P Martin1, Ying Qi, Xiaojiang Gao, Eriko Yamada, Jeffrey N Martin, Florencia Pereyra, Sara Colombo, Elizabeth E Brown, W Lesley Shupert, John Phair, James J Goedert, Susan Buchbinder, Gregory D Kirk, Amalio Telenti, Mark Connors, Stephen J O'Brien, Bruce D Walker, Peter Parham, Steven G Deeks, Daniel W McVicar, Mary Carrington.   

Abstract

Allotypes of the natural killer (NK) cell receptor KIR3DL1 vary in both NK cell expression patterns and inhibitory capacity upon binding to their ligands, HLA-B Bw4 molecules, present on target cells. Using a sample size of over 1,500 human immunodeficiency virus (HIV)+ individuals, we show that various distinct allelic combinations of the KIR3DL1 and HLA-B loci significantly and strongly influence both AIDS progression and plasma HIV RNA abundance in a consistent manner. These genetic data correlate very well with previously defined functional differences that distinguish KIR3DL1 allotypes. The various epistatic effects observed here for common, distinct KIR3DL1 and HLA-B Bw4 combinations are unprecedented with regard to any pair of genetic loci in human disease, and indicate that NK cells may have a critical role in the natural history of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17496894      PMCID: PMC4135476          DOI: 10.1038/ng2035

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  45 in total

Review 1.  HIV and SIV CTL escape: implications for vaccine design.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire.

Authors:  W Held; J R Dorfman; M F Wu; D H Raulet
Journal:  Eur J Immunol       Date:  1996-10       Impact factor: 5.532

3.  Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases.

Authors: 
Journal:  MMWR Suppl       Date:  1987-08-14

4.  A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.

Authors:  J J Goedert; C M Kessler; L M Aledort; R J Biggar; W A Andes; G C White; J E Drummond; K Vaidya; D L Mann; M E Eyster
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

5.  Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study.

Authors:  J Phair; L Jacobson; R Detels; C Rinaldo; A Saah; L Schrager; A Muñoz
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

6.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

7.  The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1.

Authors:  Marcelo J Pando; Clair M Gardiner; Michael Gleimer; Karina L McQueen; Peter Parham
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

Review 8.  The molecular descent of the major histocompatibility complex.

Authors:  J Klein; Y Satta; C O'hUigin; N Takahata
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

9.  Long-term HIV-1 infection without immunologic progression.

Authors:  S P Buchbinder; M H Katz; N A Hessol; P M O'Malley; S D Holmberg
Journal:  AIDS       Date:  1994-08       Impact factor: 4.177

10.  NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.

Authors:  M Cella; A Longo; G B Ferrara; J L Strominger; M Colonna
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  392 in total

1.  Killer cell immunoglobulin-like receptors (KIR) typing by DNA sequencing.

Authors:  Lihua Hou; Minghua Chen; Noriko Steiner; Kanthi Kariyawasam; Jennifer Ng; Carolyn K Hurley
Journal:  Methods Mol Biol       Date:  2012

2.  Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individuals.

Authors:  Jaclyn K Wright; Zabrina L Brumme; Boris Julg; Mary van der Stok; Zenele Mncube; Xiaojiang Gao; Jonathan M Carlson; Philip J R Goulder; Bruce D Walker; Mark A Brockman; Thumbi Ndung'u
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

Review 3.  Host genes important to HIV replication and evolution.

Authors:  Amalio Telenti; Welkin E Johnson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

4.  Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.

Authors:  Jeffrey D Lifson; Nancy L Haigwood
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

Review 5.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

6.  Innate immune natural killer cells and their role in HIV and SIV infection.

Authors:  Pavel Bostik; Yoshiaki Takahashi; Ann E Mayne; Aftab A Ansari
Journal:  HIV Ther       Date:  2010-07-01

7.  Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.

Authors:  Mark H Kuniholm; Andrea Kovacs; Xiaojiang Gao; Xiaonan Xue; Darlene Marti; Chloe L Thio; Marion G Peters; Norah A Terrault; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Tiffany G Harris; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

8.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Authors:  Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

9.  Another earth: innate lymphoid cells and intestinal inflammation.

Authors:  Lin Lin; Jonathan Braun
Journal:  Gastroenterology       Date:  2011-09-28       Impact factor: 22.682

Review 10.  Memory responses of natural killer cells.

Authors:  Clair D Geary; Joseph C Sun
Journal:  Semin Immunol       Date:  2017-08-30       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.